Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge. - Wikidata - wikimedia - TriplyDB

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

http://www.wikidata.org/entity/Q35535626

about

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease Approved Antiviral Drugs over the Past 50 Years Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.Chronic hepatitis B: A wave of new therapies on the horizon.Recent advances in the development of subunit-based RSV vaccines.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein.Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response.RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.The promise and challenge of epitope-focused vaccines.Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development.Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.

P2860

Q26775152-97961921-271D-4706-8138-51C44374A838 Q27755387-B9DF7C60-1B8F-4440-849C-D18B1A62A1A9 Q28067143-7E7D6258-B3FF-422F-B9AF-2EF61C3D2BDB Q36973952-D2E7CC6B-3654-4F19-B263-2F7E1BA071A5 Q38538107-684DBED4-F020-42A9-AA8C-47137EC55716 Q38617302-EE02DB94-60E4-4531-9DEF-9A6B232867AC Q39027049-11B6C6EB-A94C-4359-8BA5-3620E21EFF31 Q39076542-275201ED-3724-4C86-8A0C-F26E1D57C1D6 Q40046506-1651E729-5FF5-4D32-A288-BF16DFAF905B Q40054901-F18DE767-D644-42E1-8132-5399226D51C0 Q40565908-B3EEDC97-9F4F-48A2-8C06-6F8D32F8FE3C Q40722956-6BB5657C-A3DA-4108-9B5C-0116946C753D Q40812866-296BB7E9-DA66-4E51-A715-DFE97BB82B51 Q54209804-97672124-F3AE-463C-9F65-C8845F84B0E4

P2860

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

http://www.wikidata.org/entity/Q35535626

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@ast

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@en

type

label

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@ast

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@en

prefLabel

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@ast

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@en

P1433

Q35535626-CBD1C0FF-6D56-407C-94AC-FA7161DAFBFD

P1476

Q35535626-0DDE35F8-2954-4E79-9E22-CF17C40C2320

P2093

Q35535626-2C04DBC9-F064-4B2C-B238-9C5492FFD1F0

Q35535626-3DA1FCAD-F1A0-40D2-94DD-0F197FDF39D7

Q35535626-54A6077E-6059-4FB3-B97D-DF3EF2606627

Q35535626-5DBAA8BF-0130-45B7-B730-9FE9AB2A72EC

Q35535626-702E0359-5E3C-43EB-94E7-43C1BC1ADC10

Q35535626-844AB653-2880-4290-8397-C59119F2D89D

Q35535626-8B1AB651-50B4-4C39-84C0-7D241C8EE635

Q35535626-C5957CCF-AF2F-4BAE-8D55-F17EFAC8D5A0

Q35535626-E3D5BAA8-DACE-41BF-AF1E-C1E5647F6984

Q35535626-F82BD81E-57D1-4EDF-82B0-F7C2BDF3AF5A

P2860

Q35535626-029B53C0-14D8-49F0-B703-E86803341933

Q35535626-14674007-F833-48E7-8503-99FB2268AFC7

Q35535626-1499B321-FA69-48E4-B52D-3FA2DDE0F750

Q35535626-17F375A6-A6E3-4CA0-A2CF-67B55CDD7097

Q35535626-185D7F1E-488E-4FB7-9B93-419B4951FA16

Q35535626-1E3312B3-62D4-48F6-BD8F-E8AB0485ADE8

Q35535626-20DD202F-DDFA-4F2E-8411-25BB2CE1B285

Q35535626-24F77694-3B7C-4C8E-8AA0-7169C74ADE36

Q35535626-2C54BB07-E924-40AF-AB93-2DE7CAC54F64

Q35535626-47841DFC-D841-4334-B2AE-60EBAEC50240

P304

Q35535626-EAFCACFA-F2CB-4F8F-AE23-422A145C801E

P31

Q35535626-FA28B558-E9FB-40AA-9827-C318EE504643

P356

Q35535626-DD47C3EB-B5D1-4AF2-8DDD-8F68815823D6

P407

Q35535626-066DDE5F-B52F-4D75-9859-ED5BA7AE5EBC

P433

Q35535626-5D17CC9E-46FF-4DF6-959E-146D56EEC46B

P478

Q35535626-B62AB99B-143D-49CB-A4FE-BBBAF6CFACD3

P577

Q35535626-86A205ED-CCDB-4229-B99E-3B460A37C920

P5875

Q35535626-60967E69-ABB2-498F-B1ED-31D21E35C917

P698

Q35535626-934E287E-2440-419F-84E7-43473981C202

P932

Q35535626-35AE5453-58DE-47FC-B23A-3874B60ED8F7

P356

P1433

Journal of Clinical Investigation

P1476

Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.

@en

P2093

Cory J Peters

http://www.w3.org/2001/XMLSchema#string

Darrell L Peterson

http://www.w3.org/2001/XMLSchema#string

David C Whitacre

http://www.w3.org/2001/XMLSchema#string

David R Milich

http://www.w3.org/2001/XMLSchema#string

Gary Van Nest

http://www.w3.org/2001/XMLSchema#string

Heather Lawlor

http://www.w3.org/2001/XMLSchema#string

Jasmine Kaur

http://www.w3.org/2001/XMLSchema#string

Jeanne H Schickli

http://www.w3.org/2001/XMLSchema#string

Joyce E Jones

http://www.w3.org/2001/XMLSchema#string

Michael P McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

The crystal structure of the human hepatitis B virus capsid

Structural basis of respiratory syncytial virus neutralization by motavizumab

Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Proof of principle for epitope-focused vaccine design

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.

P304

1637-1647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI78450

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273323440

http://www.w3.org/2001/XMLSchema#string

P698

25751145

http://www.w3.org/2001/XMLSchema#string

P932

4409022

http://www.w3.org/2001/XMLSchema#string